Literature DB >> 8425441

Effects of cyclooxygenase and lipoxygenase inhibition on eicosanoids and healing of acetic acid colitis in rats.

L E LeDuc1, K C Su, E Guth, T Reedy, P H Guth.   

Abstract

Both cyclooxygenase products, such as prostaglandin (PG) E2, and lipoxygenase products, such as leukotriene (LT) B4, are increased in colitis and have potent proinflammatory actions. We studied effects of specific inhibitors of cyclooxygenase and 5-lipoxygenase on the healing of acetic acid colitis in rats. Acetic acid colitis was induced 24 hr before enzyme inhibition began. Four days after induction of colitis, the area of gross colonic mucosal damage was determined by image analysis. Eicosanoid content in the intestinal lumen was quantitated by radioimmunoassay following chromatographic purification. Under these conditions, indomethacin significantly retarded the healing of colonic lesions and inhibited PGE2 by > 90% compared to placebo-treated colitis rats. AA861 had no effect on the healing of lesions, although > 75% inhibition of leukotriene synthesis was demonstrated. These results suggest that inhibition of endogenous colonic prostaglandins can impair healing mechanisms in acute colitis even after inflammation has developed. In contrast, inhibition of leukotriene synthesis did not affect healing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425441     DOI: 10.1007/bf01307546

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

2.  Gastrointestinal ulcer formation in rabbits immunized with prostaglandin E2.

Authors:  J S Redfern; A J Blair; E Lee; M Feldman
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

3.  Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum.

Authors:  C von Ritter; M B Grisham; D N Granger
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

4.  Hypersensitive prostaglandin and thromboxane response to hormones in rabbit colitis.

Authors:  R D Zipser; J B Patterson; H W Kao; C J Hauser; R Locke
Journal:  Am J Physiol       Date:  1985-10

5.  Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

Authors:  W F Stenson; E Lobos
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.

Authors:  D S Rampton; G E Sladen
Journal:  Prostaglandins       Date:  1981-03

7.  Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.

Authors:  D S Rampton; G E Sladen
Journal:  Postgrad Med J       Date:  1981-05       Impact factor: 2.401

Review 8.  Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease.

Authors:  C C Nast; L E LeDuc
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

9.  Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

10.  Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response.

Authors:  D W Goldman; E J Goetzl
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  2 in total

1.  Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.

Authors:  X Bertrán; J Mañé; F Fernández-Bañares; E Castellá; R Bartolí; I Ojanguren; M Esteve; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

2.  The characterization of a rabbit model of inflammatory bowel disease.

Authors:  D Anthony; F Savage; V Sams; P Boulos
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.